Stock Market News
Switzerland buys Pfizer’s COVID-19 antiviral Paxlovid
2022.05.20 16:11
FILE PHOTO: Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in boxes, at Misericordia hospital in Grosseto, Italy, February 8, 2022. REUTERS/Jennifer Lorenzini/File Photo
BERLIN (Reuters) – Switzerland signed a contract to buy Pfizer (NYSE:PFE)’s anti-viral drug Paxlovid to treat Covid-19, it said on Friday.
The European country said it had signed a contract to buy 12,000 packages and first treatments for certain at-risk patients would start this month.
